This infographic from SAMHSA educates patients who use opioids on how to treat and overdose with naloxone.
This 2018 toolkit from SAMHSA offers advice for creating opioid overdose prevention programs in local communities. Specific guidance is provided for first responders, prescribers, and patients and family members in Spanish.
This 2018 toolkit from SAMHSA offers advice for creating opioid overdose prevention programs in local communities. Specific guidance is provided for first responders, prescribers, and patients and family members.
This 2017 guide from the National Institute on Drug Abuse discusses naloxone and how people can obtain the medication and use it to treat opioid overdoses in the community. The publication is aimed primarily at opioid users, their friends and family, and community members.
This 2018 publication by the College of Psychiatric and Neurologic Pharmacists presents the concept of harm reduction and presents strategies for pharmacists to adopt harm reduction concepts in their practices.
This infographic from the Recovery Research Institute instructs readers how to identify whether someone is experiencing a drug overdose and what to do if you suspect a drug overdose.
SAMHSA’s 2018 Treatment Improvement Protocol is a comprehensive discussion of medication assisted treatment for opioid use disorder. This 322 page report includes sections targeted to healthcare providers and addiction treatment professionals, policy makers, and patients and their families.
This 2009 publication by SAMHSA and the Legal Rights Center explains the federal laws that protect the rights of individuals receiving medication assisted treatment for opioid use disorder and provides guidance to individuals on how to protect their rights.
This four page document presents the highlights from the 2019 National Academies report on medication assisted treatment for opioid use disorder. Funding Source: National Institute on Drug Abuse, National Institutes of Health; Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
This one page document summarizes the conclusions of the 2019 National Academies report on medications for opioid use disorder.